post-exercise fev1
Item
demonstrate a fall in post-exercise fev1 of > 10% after dry air exercise challenge for the diagnosis of eib and
boolean
C0748133 (UMLS CUI [1,1])
C1979962 (UMLS CUI [1,2])
fev1
Item
> 12% increase in fev1 from the baseline value after the administration of a
boolean
C0748133 (UMLS CUI [1])
beta-2 agonist response
Item
β2-agonist. however, if the bronchodilator response is < 12% increase in fev1 from the baseline value then asthmatic subjects with eib must further demonstrate
boolean
C1373132 (UMLS CUI [1])
C0748133 (UMLS CUI [2,1])
C2599594 (UMLS CUI [2,2])
methacholine challenge
Item
a < 16.0 mg.ml-1 concentration of methacholine causing a 20% decrease in fev1 (pc20)
boolean
C0430567 (UMLS CUI [1])
C0748133 (UMLS CUI [2])
pregnancy
Item
subjects will be excluded if they are pregnant
boolean
C0032961 (UMLS CUI [1])
comorbidity
Item
have a history of hyperlipidemia, hypertension, diabetes, bleeding disorders, delayed clotting time
boolean
C0009488 (UMLS CUI [1])
aspirin and fev1
Item
taking aspirin medication and have a resting fev1 less than 65% predicted.
boolean
C0004057 (UMLS CUI [1])
C0748133 (UMLS CUI [2])
hematocrit
Item
a complete blood count and urinary pregnancy tests will be conducted at the beginning of the study and subjects with a hematocrit < 35 will be excluded from participation in the study.
boolean
C0518014 (UMLS CUI [1])
n-3 pufa supplements, supplements with antioxidants, fish
Item
in addition, subjects will also be excluded if they have a history of taking n-3 pufa supplements or supplements with antioxidants above the levels recommended for adequate intake, or regularly consume more than one fish meal per week.
boolean